Canopy CEO: We'll 'Disrupt the Heck' Out of Pharma
*By Carlo Versano*
At the end of a week that saw the nascent cannabis sector soar to record valuations (with enough [volatility](https://cheddar.com/videos/making-sense-of-tilrays-stock-chart) to make your head spin), at least one exec isn't getting high off his own supply.
Bruce Linton, CEO of Canopy Growth ($CGC), told Cheddar Friday that he is focused on using a recent $4 billion cash injection from Constellation Brands to accelerate his business operations as new markets open up for legal marijuana use.
The market for legal pot went from a handful of countries like Canada, where Canopy is based, to now over 30 globally, Linton said in an interview, and Constellation's stake "is the kind of rocket fuel we need."
As speculators send the stocks higher ー Canopy is up 100 percent since the August deal, while Tilray ($TLRY) is up 1,000 percent since its July IPO ー Linton is keeping his nose to the grindstone developing new uses for cannabis, illustrated by the 39 patents Canopy filed in the last year just for sleep-related cannabinoid products. He sees other uses as well, from anxiety to sports recovery, which begs the question: is Canopy a pharma company?
"We're going to have enough intellectual property and activity that it would be difficult for pharma companies...not to need to play with us," Linton said. "We're going to disrupt the heck out of them."
Speaking of disruption, Linton said he wasn't bothered by parallels with the dot-com bubble of the early 2000s. He said Canopy had more in common with a Google or Amazon ー established businesses with strong fundamentals ー than any of the internet stocks that were relegated to the tech boneyard after the bubble popped.
But for an industry like cannabis that is entirely dependent on regulation, there will always be a risk, Linton noted. For every country like Canada, which legalized medical marijuana in 2001 and will allow recreational use starting October 17, there's an Italy ー where medical marijuana is legal but heavily restricted ー or a Japan ー where it is strictly outlawed. Put another way, Canopy may have the best legal pot cultivation and distribution in the world, but its long-term success on a global scale may be capped by shifting regulatory and political climates.
Still, Linton sees the writing on the wall in places like South America, Australia, and the EU. As regulatory barriers come down, he said Canopy's strong production operations will lead the market.
"People can fight for who's going to be the second best," Linton said. "We're going to be the best and the largest and the most dominant on the planet over the next decade."
For full interview [click here](https://cheddar.com/videos/canopy-growth-blazing-a-trail).
The U.S. will be implementing a vaccine mandate for all people entering through its land borders, removing exemptions for "essential" travelers such as truckers, students, and business people. While the Canadian Trucking Alliance argues that the new, stricter rule might exacerbate ongoing auto supply chain issues, some health experts see the potential for helping curb the ongoing pandemic. Anthony Santella, a professor of health administration at the University of New Haven, joined Cheddar to give his take on the updated border crossing restriction. "We can't just focus on one type of travel. We need to ensure that it's clear and consistent across all types of travel," Santella said.
Will Rhind, CEO of GraniteShares, joins Cheddar News' Closing Bell, where he says he believes the Fed's plans of increasing rates is taking its toll on some of the more speculative stocks and the technology market.
Melissa Gonzalez, CEO and Founder of The Lionesque Group, joins Cheddar News' Closing Bell, where she explains why she feels mixed about the Walmart's new initiative and what will make mass adoption of this offering difficult.
Exercise equipment maker Peloton is attempting to run away from a recent bout of controversy. CEO John Foley published an open letter to employees on Thursday after reports that said Peloton was pausing production of its Bike and Tread products, delaying the opening of a new U.S. factory, and considering job cuts. In the letter, Foley wrote that the information in the reports was 'incomplete,' 'out of context,' and not reflective of Peloton's strategy. Peloton's stock responded on Friday, with shares bouncing back after falling nearly 24% in the regular session on Thursday. CFRA Research's Director of Research Ken Leon joined Cheddar News' Closing Bell to discuss.
Home essentials maker Outlines announced its launch at the beginning of 2022, along with $1 million in pre-seed funding led by Social Impact Capital. Outlines says it is re-imagining how we keep our homes clean while also reducing plastic waste. The company's debut product, the Shower Liner System, is made of long-lasting materials, including easy-to-recycle plastic. Outlines co-founder and CEO Luke Young and co-founder and COO Megan Ceryanec joined Cheddar News' Closing Bell to discuss.
Despite Netflix's successful fourth-quarter earnings report, investors are hitting the 'pause' button after the company admitted that competition from other streaming platforms could eat into growth. Netflix is also lowering expectations for expected subscriber growth for the first quarter of this year, anticipating it will add just 2.5 million, far below the 3.98 million subscribers it added during the same quarter one year ago. What could happen to the streaming giant as the streaming wars keep heating up? Greg Martin, Co-Founder of Rainmaker Securities, joins Cheddar News' Closing Bell to discuss whether Netflix could lose its top spot, how it's trying to compete with other platforms, the streaming industry landscape, and more.
